| 2021-01-04 | Roberts Christopher D. | Chief Scientific Officer | Sale+OE | 1,963 | $31.31 | $61,460.16 | -34.4% | → |
| 2021-01-04 | Epstein David M. | See Remarks | Sale+OE | 9,985 | $30.99 | $309,430.16 | -1.4% | → |
| 2020-12-14 | Hatzis-Schoch Brent | See Remarks | Sale+OE | 4,078 | $34.95 | $142,522.43 | -57.6% | → |
| 2020-12-08 | Leggett Thomas | Chief Financial Officer | Sale+OE | 3,000 | $33.78 | $101,326.80 | -60.7% | → |
| 2020-12-03 | Roberts Christopher D. | Chief Scientific Officer | Sale+OE | 2,500 | $32.42 | $81,055.25 | -100% | → |
| 2020-12-01 | Epstein David M. | See Remarks | Sale+OE | 12,000 | $32.71 | $392,573.74 | -0.8% | → |
| 2020-11-30 | Versant Venture Capital VI, L.P. | - | Sell | 10,393 | $33.15 | $344,512.74 | -0.6% | → |
| 2020-11-30 | Bolzon Bradley J PhD | - | Sell | 10,393 | $33.15 | $344,512.74 | -0.6% | → |
| 2020-11-19 | Versant Venture Capital VI, L.P. | - | Sell | 130,017 | $33.01 | $4,291,861.17 | -2.2% | → |
| 2020-11-19 | Bolzon Bradley J PhD | - | Sell | 130,017 | $33.01 | $4,291,861.17 | -2.2% | → |
| 2020-11-18 | Bolzon Bradley J PhD | - | Sell | 4,730 | $33.05 | $156,349.14 | - | → |
| 2020-11-18 | Versant Venture Capital VI, L.P. | - | Sell | 4,730 | $33.05 | $156,349.14 | - | → |
| 2020-11-16 | Versant Venture Capital VI, L.P. | - | Sell | 4,700 | $33.74 | $158,586.75 | - | → |
| 2020-11-16 | Bolzon Bradley J PhD | - | Sell | 4,700 | $33.74 | $158,586.75 | - | → |
| 2020-11-12 | Hatzis-Schoch Brent | See Remarks | Sale+OE | 4,078 | $33.99 | $138,606.55 | -25.7% | → |
| 2020-11-12 | Bolzon Bradley J PhD | - | Sell | 15,598 | $34.15 | $532,641.99 | - | → |
| 2020-11-12 | Versant Venture Capital VI, L.P. | - | Sell | 15,074 | $34.17 | $515,099.84 | - | → |